Teleron, Junrex .
HRN: 16-82-76 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/07/2022
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
07/07/2022
07/13/2022
ORAL
2.5ml
Bid
Uti
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes